COVID booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say
This post was originally published on this siteThe CDC has said it’s safe to mix vaccine brands, and data suggests Pfizer-BioNTech or Moderna would be more protective than a second J&J shot.
J&J to Split Into Two Public Companies
This post was originally published on this siteJohnson & Johnson intends to separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.
FDA advisory committee to consider boosters for Moderna and J&J COVID-19 vaccines
This post was originally published on this sitePeople who received Moderna and J&J COVID vaccines have been in limbo about booster shots. A key FDA committee will recommend if they are necessary.
